Phase III ASCENT Study of Metastatic TNBC Halted Due to Compelling Efficacy

by Fitcoachion | Last Updated: April 11, 2020

The decision to halt the study was based on the unanimous recommendation by an independent data safety monitoring committee during its routine review of the ASCENT study.